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Abstract
 Background—Understanding tumor characteristics is likely important but little is known 
about breast cancer patients’ knowledge of their disease. We assessed women's knowledge about 
their tumor characteristics, whether racial/ethnic disparities in knowledge exist, and whether 
education and health literacy influenced associations.
 Methods—We surveyed a population-based cohort of women in Northern California with 
stage 0-III breast cancer diagnosed during 2010-2011 (participation rate=68.5%). Among 500 
respondents (222 non-Hispanic white, 142 non-Hispanic black, and 136 Hispanic women), we 
examined racial/ethnic differences in knowledge about tumor characteristics (estrogen receptor 
[ER], Human Epidermal Growth Factor Receptor 2 [HER2], stage, grade) and correctness of 
tumor information (with California Cancer Registry data for confirmation). We used multivariate 
logistic regression to assess the probability of (a) ‘knowing’ tumor stage, receptor status, and 
grade and (b) ‘correctly answering’ tumor information by race/ethnicity. In sequential models, we 
examined the impact of education and health literacy on findings.
 Results—Overall, 32%-82% reported knowing each of the 4 tumor characteristics and 
20%-58% correctly reported these characteristics. After adjustment, black and Hispanic women 
were less likely than white women to know and have correct responses for stage, ER, and HER2 
(all P<.05). Education and health literacy were significantly associated with knowing and having 
correct information for some characteristics, but these variables did not eliminate most of the 
racial/ethnic differences observed.
 Conclusions—Knowledge about one's breast cancer was generally poor, particularly for 
minority women. Further study of how this knowledge may impact receipt of care and outcomes is 
warranted.
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Precis: Knowledge about one's breast cancer characteristics is generally poor for all patients, and 
minority, less educated, and older women are the least likely to know and correctly report 
characteristics.
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 INTRODUCTION
Having knowledge about one's health conditions or the risk of developing health conditions 
can promote healthy behaviors and treatment adherence.1-3 Better general knowledge about 
cancer is associated with cancer screening,4-6 earlier stage at presentation and survival,7, 8 
and enhanced satisfaction with care.9, 10 Despite these benefits, general cancer knowledge is 
poor overall,10-13 and many women with breast cancer want more information from their 
providers.14 Prior studies of cancer knowledge have mainly focused on understanding 
treatment options, rationales, and the associated risks.10-13, 15 However, for cancer patients, 
understanding characteristics of one's cancer, such as stage and receptor status, is also likely 
important. Such tumor-specific knowledge may lead to a better understanding of treatment 
rationale (e.g., endocrine therapy for hormone receptor-positive tumors), enhanced decision-
making, better treatment adherence, and more empowered patients. To our knowledge, prior 
studies have not examined breast cancer patients’ knowledge about their own disease.
Racial disparities in breast cancer treatment and outcomes are pervasive and the reasons for 
lower rates of guideline-recommended care for racial/ethnic minorities are complex. Racial/
ethnic differences in knowledge about one's breast cancer characteristics, if present, could 
potentially contribute to differences in treatment receipt and adherence. In addition, past 
studies have suggested that lower health literacy, educational attainment, and income are 
associated with knowledge about health conditions.16-19 Because health literacy20-24 and 
socioeconomic status25 are often lower in minority patients, these factors could contribute to 
suboptimal knowledge for minority patients.
We surveyed a diverse, population-based cohort of women with breast cancer in Northern 
California to assess differences in knowledge of individual tumor characteristics by race/
ethnicity. We also assessed whether differences in educational attainment and health literacy 
explained any racial/ethnic differences in knowledge.
 METHODS
 Study Population
We identified 1,118 white, black, or Hispanic women who underwent primary surgery for a 
stage 0-III breast cancer diagnosed during 2010-2011 in Regions 1/8 (San Francisco/Santa 
Clara) and Region 3 (Sacramento) of the California Cancer Registry (CCR). These areas 
cover 22 counties and over 9 million residents.26 The registries (both part of the Surveillance 
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Epidemiology, and End Results program) uniformly collect information on patient 
demographics, tumor characteristics, primary treatments, and mortality for all incident 
cancers in these regions. We obtained study approvals from the CCR, the California Health 
and Human Services Agency Committee for the Protection of Human Subjects, and the 
Harvard Medical School Committee on Human Studies.
 Survey Administration and Patient Enrollment
We mailed letters to eligible patients in English and Spanish inviting them to participate 
voluntarily in a confidential survey about their breast cancer care. The mailing included a 
postage-paid opt-out card if they preferred not to be contacted and a toll-free number to call 
to participate or opt-out. Patients who did not opt out but whom we did not reach by phone 
received a second mailing. At least 6 telephone calls were attempted at different times and 
on different days. Participants provided verbal consent before the interview began and 
received a $20 incentive upon interview completion. Interviews were conducted by trained 
study staff using computer assisted telephone interview software.
 Survey
Participants were asked about their breast cancer characteristics (Table 1), including tumor 
stage, grade, and receptors (estrogen receptor [ER], progesterone receptor [PR], Human 
Epidermal Growth Factor Receptor 2 [HER2]); all questions included the option “don't 
know”. We also asked about treatments received27 and collected information on self-
reported race/ethnicity, educational attainment,28 household income,28 insurance coverage,28 
health literacy,29 and comorbidity.28 We performed cognitive testing with 10 patients (in 
English and Spanish) before the instrument was finalized to ensure feasibility and clarity, 
resulting in minimal changes to the question sequence only.
 Response Rates
Among the 1,118 patients (Figure 1), 231 refused participation, 317 could not be reached, 68 
were deceased/too ill, and 502 women were surveyed. Two of these 502 women self-
identified as Asian and were excluded. The response rate (using American Association for 
Public Opinion Research [AAPOR] methods) was 47.8%; the participation rate among those 
for whom we had contact information was 68.5%. White women were less likely to have no 
contact information (15%) compared with black (25%) and Hispanic (23%) women. 
However, after exclusion of those without contact information (n=227), respondents (n=502) 
(vs. non-respondents [n=389]) were similar with regard to race/ethnicity and tumor 
characteristics, although respondents were younger (mean age=58 vs. 64;p<.0001). Seventy 
of 136 Hispanic women were interviewed in Spanish.
 Variables of Interest
We examined whether participants reported ‘knowing’ their breast cancer characteristics 
(ER/HER2/grade/stage) as well as the ‘correctness’ of participant-reported breast cancer 
characteristics using CCR data. ‘Knowing’ tumor characteristics was defined as providing 
an answer (correct or incorrect) to specific questions about the characteristics (Table 1) 
versus responding “I don't know”. Answers were considered ‘correct’ if a participant's 
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answer matched the tumor characteristic according to the CCR or if the CCR result was 
“unknown,” “not performed,” or missing. Women who reported having stage IV disease 
(N=12) were considered to correctly report stage because their cancer (originally diagnosed 
as stage 0-III) may have recurred.
 Independent Variables
Independent variables of interest included race/ethnicity, educational attainment, and health 
literacy.29 We assessed health literacy using three questions:29 (1) “How confident are you 
filling out medical forms,” (2) “How often do you have problems learning about your 
medical condition?,” and (3) “How often do you have someone help you read hospital 
materials?” Responses used a 5-item Likert scale. After reversing responses for the first 
item, we assigned each of these answers a score of 1-5 (lowest number consistent with the 
most confidence/fewest problems) and calculated the mean of the three scores as a summary 
variable. One participant did not answer question (2) above; we used the mean of her two 
other responses. Control variables were categorized as in Table 2 and included age, marital 
status, insurance status at diagnosis, and number of comorbidities. We also collected 
household income (Table 1) but because this variable was highly correlated with education, 
we did not include it in adjusted analyses.
 Statistical Analysis
We used the χ2 and Kruskal-Wallis tests to assess differences in baseline characteristics by 
race/ethnicity and the χ2 test to assess associations between race/ethnicity and ‘knowing’ 
and ‘correctly answering’ questions. We then performed a series of logistic regression 
models to examine the probability of (a) ‘knowing’ and (b) ‘correctly answering’ questions 
about stage, grade, ER, and HER2. For each tumor characteristic endpoint, we performed 
three models. First, we included race/ethnicity, adjusting for age, marital status, insurance, 
and comorbidity (i.e. base model). We next repeated models also including education, 
followed by a model which also included health literacy. We also performed ordinal logistic 
regression models for the summed outcomes of (a) knowing more characteristics (0-4) and 
(b) correctly answering questions (0-4).
Because grade, HER2 status, and other tumor features are less emphasized in the setting of 
noninvasive disease, we repeated all analyses after excluding patients with stage 0 cancers 
(N=86). Results were similar and are not presented.
In an exploratory analysis, we examined whether women with ER or PR-positive disease 
(according to CCR data) who reported knowing or having correct ER status were more 
likely to report taking hormonal treatment than women who reported they did not know or 
answered incorrectly.
 RESULTS
Characteristics of the cohort by race/ethnicity are shown in Table 2. In general, Hispanic 
participants were younger than other groups and white and Hispanic patients were more 
likely married. Hispanic women had lower educational attainment and lower household 
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incomes compared with black and white women and were less likely to be insured at 
diagnosis.
Overall, 55% reported knowing ER status, 33% reported knowing HER2 status, 82% 
reported knowing stage, 32% reported knowing grade, and 14% reported knowing all four 
characteristics; 14% reported knowing no characteristics. Approximately 56% reported 
correct ER, 58% reported correct HER2, 57% reported correct stage, 20% reported correct 
grade, and 8% had all four questions correct. In general, minority participants were less 
likely to report knowing or answering questions correctly for multiple tumor characteristics, 
including stage and receptors (Figure 2).
In adjusted analyses (Table 3), the results of the base models revealed racial/ethnic 
differences for all outcomes, with exception of knowing and having correct grade and 
correct HER2 status, with black and Hispanic (vs. white) women having consistently lower 
odds of knowing and correctly answering questions. When education was added to models, 
the findings for black women did not significantly change across all outcomes examined. 
However, for Hispanic women, odds ratios for several models changed by >20%, with 
findings becoming non-significant in both stage models and in the correct HER2 model 
(Table 3). Adding health literacy in the final models did not change results for black women 
but narrowed differences for Hispanic (vs. white) women in models for both ER variables, 
knowing HER2, knowing more answers, and having more answers correct. In addition, older 
age (particularly age >70 vs. age <50) was consistently associated with less knowledge and 
correctness with exception of the grade models. Less education and lower reported health 
literacy were also associated with various outcomes (Table 4).
Approximately 80% of the 336 women with ER or PR-positive disease per CCR data 
reported taking hormonal therapy; knowing and correctly reporting ER status was associated 
with hormonal therapy use. Rates of self-reported treatment were 86% among women who 
knew versus 71% among women who did not know their ER status. Similarly, among 
women who reported ER-positivity correctly, 88% reported taking hormonal therapy versus 
69% of those answering ER incorrectly (p<.05 for both).
 DISCUSSION
In this large, diverse, population-based cohort of breast cancer patients, we observed low 
rates of knowing and correctly reporting tumor information, with minority patients less 
likely than white patients to have information about their cancers. Lower educational 
attainment and lower health literacy were also associated with less knowledge about one's 
cancer. Nevertheless, differences in education and health literacy did not eliminate most of 
the observed differences for minority participants.
Our results dramatically illustrate the lack of understanding many patients have about their 
cancers and have identified a critical need for improved patient education and provider 
awareness of this issue. Although many factors contribute to disparities in care and 
outcomes, improving knowledge about one's tumor characteristics is a mutable factor that is 
likely amenable to educational interventions. Improving patients’ understanding about why a 
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particular treatment is important for her individual situation (i.e. hormonal therapy because 
she has ER-positive disease or trastuzumab because she has HER2-positive disease) may 
lead to more informed decisions and better adherence to treatment plans. In addition, 
complementary interventions focusing on providers and how they transmit information to 
patients is essential to improved communication and comprehension of one's disease. Past 
studies have illustrated the tendency of minority patients to ask fewer questions and to 
participate less actively in care than white patients, with more reliance on providers for 
treatment recommendations.30-32 Because of differences in patient needs, providers may 
need to tailor the way they transmit information to patients about their disease. In addition to 
cultural competency training, additional work is needed to understand how physicians can 
best assess patients’ specific information needs and knowledge base and most effectively 
communicate information to them.
In exploratory analyses, we observed that knowledge about ER is associated with hormonal 
therapy for women with ER/PR-positive cancers, an important finding given the high rates 
of treatment non-adherence.33 Although prior knowledge intervention studies have focused 
on general treatment and cancer knowledge, this work suggests that cancer information, 
often in the form of decision aids, may increase general breast cancer knowledge15, 34, 35 
and that a better understanding of general treatment benefits is associated with higher 
treatment rates.11, 13, 36 A qualitative study of 49 black breast cancer patients found that 
many lacked knowledge about their diagnoses and treatments, and those with a better 
understanding more often adhered to treatments.37 This study, other qualitative work,10 and 
our exploratory findings about the receipt of hormonal therapy support a hypothesis that 
improved general knowledge as well improved understanding of one's tumor characteristics 
and the reasons for personalized treatment recommendations may improve adherence and 
ultimately, outcomes. In addition, improved knowledge about one's own disease may impact 
a woman's trust, communication, confidence, and satisfaction with her treatment team.
Our findings of lower knowledge and correctness associated with worse health literacy and 
lower educational attainment were consistent with other evidence that low health literacy is 
associated with poor knowledge about health conditions.16, 18, 19, 38 Despite literacy and 
knowledge being distinct entities, a connection between literacy and cancer knowledge 
likely exists because of the potential challenges in gaining knowledge in the setting of lower 
health literacy. We also observed lower odds of knowledge and correctness for older 
patients, who may be more likely to prioritize other comorbidites, have memory loss, or 
participate in care less actively, possibly because of involvement of caregivers or because of 
poor health literacy.20, 39-41
To our knowledge, this is the first study to examine women's knowledge about their own 
disease characteristics. We surveyed a large number of women in their primary language and 
collected health literacy and socioeconomic information. However, the study has several 
limitations. First, our definitions of correctness relied on the accuracy of registry data and 
we did not have access to medical records. Nevertheless, prior studies have shown relatively 
accurate tumor stage reporting in registries compared with medical records, particularly for 
early-stage cancers.42 To avoid misclassification of women who reported information about 
their tumors when CCR data were not available, we considered answers correct whenever 
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registry data were missing/unknown for that characteristic. Overall, for the 396 women in 
our study who reported their stage (0-III), 69% matched the staging provided by the CCR. 
Second, our health literacy measure, although previously validated,29 was a brief screening 
measure only, selected to minimize patient burden. Third, although population-based, this 
study included women in Northern California only. Fourth, we cannot rule out non-response 
bias, although responders did not differ from non-responders by race/ethnicity and tumor 
characteristics. Moreover, because we surveyed women up to three years after their breast 
cancer diagnosis, it is possible that recall bias contributed to the lack of knowledge for some 
women. However, one would expect that knowledge about one's tumor characteristics would 
remain stable over time, particularly for those with ER-positive or HER2-positive disease, 
for whom prolonged treatments are often recommended.
In summary, our findings underscore the major deficits in women's knowledge about their 
cancers, with minority patients less likely than white women to know and report accurate 
information about their tumor characteristics. These observations highlight the need to better 
educate our patients about their tumors and to further examine how knowledge about one's 
cancer may contribute to receipt of care, adherence, and ultimately, outcomes.
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Schema for participant enrollment
American Association for Public Opinion Research Response Rate=502/(1118-68)=47.8%; 
refusal rate=231/(1118-68)=22%; Participation rate among women contacted=502/
(1118-68-317)=68.5%
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Figure 2a demonstrates the proportion of patients who reporting knowing (4 left bars) or 
correctly answering (4 right bars) information about their tumor stage, grade, ER status, and 
HER2 status for women who are white (yellow bars), black (red bars), or Hispanic (black 
bars). Figure 2b demonstrates the summed number of tumor characteristics known (3 left 
bars) or correctly reported (3 right bars) by race/ethnicity. The proportion of individuals 
knowing or correctly reporting 0 of the 4 characteristics is shown in yellow, 1 known/correct 
is shown in red, 2 known/correct in black, 3 known/correct in gray, and 4 (all) known/correct 
in blue.
Abbreviations: ER=estrogen receptor, HER2=Human Epidermal Growth Factor Receptor 2
*p-values using chi-square tests
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Table 1
Survey questions about breast cancer knowledge
a
What was the stage of your breast cancer? Was it 0, 1, 2, 3, or 4?
What was the grade of your cancer? Was it...
    ○ Low grade, well differentiated, or grade 1
    ○ Intermediate grade, moderately differentiated, or grade 2
    ○ High grade, poorly differentiated, or grade 3
Was your cancer subtype HER2-positive, also called Human Epidermal Growth Factor Receptor 2-positive?
    ○ Yes
    ○ No
Was your breast cancer estrogen receptor-positive?
    ○ Yes
    ○ No
a
Patients could answer “I don't know” for any of the above questions
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Table 3
Adjusted odds ratios [OR] (95% confidence interval) for race/ethnicity in sequential models for knowing and 
having correct tumor information (n=500)
Model
a





Base model 0.47 (0.25-0.89) 0.37 (0.20-0.68)
+Education 0.49 (0.25-0.93) 0.70 (0.34-1.43)
+Health Literacy 0.51 (0.26-0.98) 0.94 (0.44-2.01)
Know grade
Base model 0.65 (0.40-1.05) 0.79 (0.49-1.27)
+Education 0.64 (0.39-1.05) 0.96 (0.57-1.60)
+Health Literacy 0.65 (0.39-1.06) 1.03 (0.61-1.75)
Know ER
Base model 0.37 (0.23-0.60) 0.24 (0.15-0.40)
+Education 0.36 (0.22-0.60) 0.46 (0.26-0.81)
+Health Literacy 0.37 (0.22-0.62) 0.54 (0.30-0.95)
Know HER2
Base model 0.70 (0.42-1.19) 0.15 (0.08-0.28)
+Education 0.69 (0.40-1.18) 0.20 (0.11-0.39)
+Health Literacy 0.69 (0.40-1.19) 0.23 (0.12-0.45)
Know more characteristics
c
Base model 0.50 (0.33-0.75) 0.30 (0.20-0.46)
+Education 0.48 (0.32-0.72) 0.47 (0.31-0.73)
+Health Literacy 0.48 (0.32-0.73) 0.54 (0.35-0.85)
Correctly reports characteristic
Correct stage
Base model 0.57 (0.36-0.91) 0.56 (0.35-0.89)
+Education 0.58 (0.36-0.93) 0.74 (0.44-1.22)
+Health Literacy 0.59 (0.37-0.95) 0.82 (0.49-1.37)
Correct grade
Base model 0.60 (0.33-1.07) 0.69 (0.40-1.20)
+Education 0.61 (0.34-1.10) 0.83 (0.46-1.51)
+Health Literacy 0.62 (0.34-1.11) 0.92 (0.51-1.69)
Correct ER
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Model
a
Race/ethnicity (all ORs are vs. white women)
b
Black Hispanic
Base model 0.38 (0.24-0.62) 0.27 (0.17-0.44)
+Education 0.38 (0.23-0.62) 0.51 (0.30-0.88)
+Health Literacy 0.39 (0.24-0.64) 0.55 (0.32-0.97)
Correct HER2
Base model 0.71 (0.44-1.13) 0.52 (0.33-0.83)
+Education 0.72 (0.45-1.14) 0.63 (0.38-1.04)
+Health Literacy 0.72 (0.45-1.15) 0.65 (0.38-1.08)
More characteristics correct
c
Base model 0.42 (0.28-0.64) 0.34 (0.23-0.51)
+Education 0.42 (0.28-0.63) 0.54 (0.35-0.83)
+Health Literacy 0.42 (0.28-0.63) 0.60 (0.38-0.94)
a
Using logistic regression; base models include race/ethnicity, insurance, comorbidity, and marital status.
b
Bolded results reflect p<.05
c
Using ordinal logistic regression after summing responses
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